Multicenter study led by NCCC shows vastly improved turnaround time to get results from the lab to the oncologist using the newest technology in the cancer testing space.
In this Q&A series, Jason Faris, MD details some exciting and innovating early-phase trials underway at the cancer center.
Dartmouth researchers have created an AI model to classify colorectal polyps on histology slides. Evaluation using 238 slides from 24 institutions across 13 US states finds that the model performs as well as practicing pathologists.
A common anti-diabetes drug being tested in many clinical trials as an anti-cancer agent activated fat metabolism that promoted the survival of dormant breast cancer cells, suggesting that the drug has context-dependent effects on cancer cells.
Programming machine learning for cervical cancer screening, aiding survival of cancer-fighting immune cells, and measuring clinician emotion during difficult conversations. These are just some of the new cancer research studies funded by The Prouty.
An internationally collaborative group of Dartmouth and Honduran researchers and oncologists found a high level of compliance with referral to clinical follow-up among rural Honduran women and men attending cancer screening events.
In this Q&A series, Jason Faris, MD, director of the Early-Phase Trials Program at Norris Cotton Cancer Center explains what early-phase clinical trials are and why they are so important to the advancement of cancer care.
Using specialty cameras and an oxygen probe drug injection, researchers at Dartmouth’s Norris Cotton Cancer Center can now image oxygen from within cancer tumors during radiation while the probe is excited by Cherenkov light, a byproduct of radiation.
A research team led by Dartmouth’s Norris Cotton Cancer Center learns how a certain immune checkpoint inhibitor molecule acts like “brakes,” quieting the immune system from responding to cancer.
Researchers at Dartmouth’s Norris Cotton Cancer Center observed that blocking a cellular receptor not only prevented but reversed obesity, with no ill side effects, in mice.